Gaps in the continuum of care among people living with HIV in Afghanistan
- PMID: 34907832
- PMCID: PMC8923977
- DOI: 10.1177/09564624211055299
Gaps in the continuum of care among people living with HIV in Afghanistan
Abstract
Background: Afghanistan adopted a "test and treat" strategy for all people living with HIV (PLWH) in 2016. In this study, we presented demographic and clinical characteristics of all people diagnosed between 2013 and 2019 and evaluated progress towards 90-90-90 UNAIDS targets and identified program gaps among PLWH in Afghanistan diagnosed in 2018.
Methods: We used clinical, behavioral, and demographic data from national HIV surveillance for 1394 patients diagnosed from 2013 through 2019. We also tracked 184 patients diagnosed with HIV in 2018 over 15 months to assess their enrollment in care, antiretroviral therapy (ART) initiation, retention on ART, and viral suppression.
Results: Of 1394 patients diagnosed from 2013 through 2019, 76.0% were male, 73.7% were older than 24 years, and 33.4% acquired HIV through heterosexual sex. Of the 184 patients diagnosed in 2018, 94.6% were enrolled in care, 88.6% received ART, 84.2% were retained on ART for at least 12 months, and 33.7% received a viral load test. Of those with a viral load test, 74.2% were virally suppressed. Patients who were 35-44 years old (52.0%, p-value .001), acquired HIV through unsafe injection (62.5%, p-value .413), were co-infected with hepatitis C virus (HCV) (60.0%, p-value .449), and with CD4 > 500 at diagnosis (64.7%, p-value .294) were less likely to be virally suppressed 12 months after diagnosis.
Conclusion: Nearly 95% of people diagnosed with HIV in Afghanistan in 2018 were linked to care and nearly 90% were on ART. Viral testing and viral suppression remain low with notable disparities for middle-aged patients, and possibly for those who injected drugs. Addressing barriers to HIV programs in Afghanistan, particularly for people who inject drugs (PWID), are urgently needed to reach the 90-90-90 global targets. Surveillance data on the number of people with undiagnosed HIV is needed to assess the first 90 target.
Keywords: Afghanistan; HIV infections; antiretroviral agents; continuity of patient care; viral load.
Figures
References
-
- UNAIDS. UNAIDS Data 2020. Available from https://www.unaids.org/sites/default/files/media_asset/2020_aids-data-bo.... 2020.
-
- Johns Hopkins Bloomberg School of Public Health MoPHA, National AIDS Control Program (Afghanistan). Afghanistan Integrated Biological and Behavioral Surveillance Survey 2012. 2012.
-
- Ministry of Public Health. Country Progress Report for National AIDS Control Program Afghanistan. Available from https://www.unaids.org/sites/default/files/country/documents/AFG_narrati.... 2014.
-
- Ministry of Public Health, National AIDS Control Program A. Consolidated Guidelines on use of Antiretroviral Drugs for Treating and Preventing HIV Infection. Kabul Afghanistan.2020. p. 118.
-
- Girum T, Yasin F, Wasie A, Shumbej T, Bekele F, Zeleke B. The effect of “universal test and treat” program on HIV treatment outcomes and patient survival among a cohort of adults taking antiretroviral treatment (ART) in low income settings of Gurage zone, South Ethiopia. AIDS Res Ther. 2020;17(1):19. - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
